Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Advances in Brief

Age-associated Risk of Cancer among Individuals with N-Acetyltransferase 2 (NAT2) Mutations and Mutations in DNA Mismatch Repair Genes

Marsha L. Frazier, Frederick T. O’Donnell, Shouming Kong, Xiangjun Gu, Imelda Campos, Rajyalakshmi Luthra, Patrick M. Lynch and Christopher I. Amos
Marsha L. Frazier
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frederick T. O’Donnell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shouming Kong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiangjun Gu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Imelda Campos
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rajyalakshmi Luthra
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick M. Lynch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher I. Amos
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published February 2001
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

  • Table 1

    Genotype analysis of 86 patients with mutations in MMR genes at each of three NAT2 loci

    NAT2 locusWT/WTaWT/MbM/MTotal Nc
    NAT2*5 qd = 0.34 (56/168)39341184
    NAT2*6 q = 0.30 (51/170)44311085
    NAT2*7 q = 0.07 (11/168)7311084
    • a WT, wild type at NAT2 locus indicated in first column.

    • b M, mutant at NAT2 locus indicated in first column.

    • c Not equal to total number of subjects because we were unable to obtain genotypes for some. All of the subjects that were genotyped for each locus are presented in this table including both affected and unaffected subjects.

    • d q, allele frequency.

  • Table 2

    Median time to diagnosis (years) for CRC and all of the cancers for all of the subjects stratified by NAT2 genotype and number of affected individualsa

    CancerNAT2 locus(WT/WTb)(WT/Mc)(M/M)
    CRC NAT2*5 50.0 (n = 21)48.0 (n = 22)36.0 (n = 5)
    NAT2*6 47 (n = 24)57.1 (n = 17)46.7 (n = 8)
    NAT2*7 53.6 (n = 42)46.7 (n = 6)(n = 0)
    All cancers NAT2*5 48.0 (n = 25)48.0 (n = 22)43.0 (n = 6)
    NAT2*6 42.0 (n = 27)57.0 (n = 19)42.0 (n = 8)
    NAT2*7 48.0 (n = 46)39.5 (n = 7)(n = 0)
    • a n, number of affected individuals.

    • b WT, wild type at NAT2 locus indicated in second column.

    • c M, mutant at NAT2 locus indicated in second column.

  • Table 3

    Cox proportional hazard regression of risk of CRC and cancer stratified by NAT2 genotype

    Univariate resultsMultivariate results (adjusted by NAT2*5, NAT2*6, and NAT2*7)
    HR95% CI-La95% CI-UbPHR95% CI-L95% CI-UP
    CRC
    NAT2*5 (wtc/wt)11
    NAT2*5 (wt/md)1.700.9692.9850.06402.381.3324.2510.0034
    NAT2*5 (m/m)1.200.3883.6910.76001.60.4955.1810.4300
    NAT2*6 (wt/wt)11
    NAT2*6 (wt/m)0.620.3511.0860.09400.750.4151.3500.3300
    NAT2*6 (m/m)0.940.3682.3700.89001.820.5865.6740.3000
    NAT2*7 (wt/wt)11
    NAT2*7 (wt/m)2.100.9894.4750.05302.961.2806.8540.0120
    NAT2*7 (m/m)
    Cancer
    NAT2*5 (wt/wt)11
    NAT2*5 (wt/m)1.220.6862.1630.50001.340.7302.4600.3500
    NAT2*5 (m/m)1.10.4352.7760.84001.130.4093.1060.8200
    NAT2*6 (wt/wt)11
    NAT2*6 (wt/m)0.590.3401.0310.06400.630.3271.2160.1700
    NAT2*6 (m/m)0.70.2661.8230.46000.940.3002.9480.9200
    NAT2*7 (wt/wt)11
    NAT2*7 (wt/m)2.821.7614.5460.000013.371.9185.9090.00004
    NAT2*7 (m/m)
    • a CI-L, lower boundary of 95% confidence interval.

    • b CI-U, upper boundary of 95% confidence interval.

    • c WT, wild type at this NAT2 locus.

    • d M, mutant at this NAT2 locus.

PreviousNext
Back to top
Cancer Research: 61 (4)
February 2001
Volume 61, Issue 4
  • Table of Contents

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Age-associated Risk of Cancer among Individuals with N-Acetyltransferase 2 (NAT2) Mutations and Mutations in DNA Mismatch Repair Genes
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Age-associated Risk of Cancer among Individuals with N-Acetyltransferase 2 (NAT2) Mutations and Mutations in DNA Mismatch Repair Genes
Marsha L. Frazier, Frederick T. O’Donnell, Shouming Kong, Xiangjun Gu, Imelda Campos, Rajyalakshmi Luthra, Patrick M. Lynch and Christopher I. Amos
Cancer Res February 2 2001 (61) (4) 1269-1271;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Age-associated Risk of Cancer among Individuals with N-Acetyltransferase 2 (NAT2) Mutations and Mutations in DNA Mismatch Repair Genes
Marsha L. Frazier, Frederick T. O’Donnell, Shouming Kong, Xiangjun Gu, Imelda Campos, Rajyalakshmi Luthra, Patrick M. Lynch and Christopher I. Amos
Cancer Res February 2 2001 (61) (4) 1269-1271;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Conditional Expression of K-ras in an Epithelial Compartment that Includes the Stem Cells Is Sufficient to Promote Squamous Cell Carcinogenesis
  • 2-Arachidonoylglycerol
  • Crucial Role of Phospholipase Cε in Chemical Carcinogen-Induced Skin Tumor Development
Show more Advances in Brief
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement